Bearish flow noted in Novartis (NVS) with 1,936 puts trading, or 3x expected. Most active are Apr-25 105 puts and Apr-25 110 puts, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 6.13, while ATM IV is up over 1 point on the day. Earnings are expected on April 29th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- Morgan Stanley says Fabhalta’s label leaves opportunity for Apellis’ Empaveli
- Novartis gets third FDA approval for oral Fabhalta
- Novartis’s treatment of leishmaniasis granted FDA orphan designation
- Patient Fatality Forces Reality Check on Sarepta Therapeutics Stock (SRPT)
- Novartis announces results from Phase III program for OAV101 IT
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue